SCHEMBL355678

SCHEMBL355678

CCN(CC)c1ccc(I)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
TSHR P16473 3/20 0.58
GFER P55789 2/20 0.58
MAPK1 P28482 2/20 0.58
PSMD14 O00487 1/20 0.58
CYP3A4 P08684 1/20 0.58
RECQL P46063 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
ALDH3A1 P30838 1/20 0.54
ALDH1A3 P47895 1/20 0.54
KDM4E B2RXH2 3/20 0.47
GAA P10253 3/20 0.47
CNR2 P34972 1/20 0.47
TERT O14746 1/20 0.45
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
MAPT P10636 4/20 0.44
HPGD P15428 2/20 0.44
HSP90AA1 P07900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1735497 0.86 ALDH1A1 (0.74) ALDH1A1L3MBTL1TSHRGFERMAPK1
Hydrochloric Acid SCHEMBL8046149 0.83 ALDH1A1 (0.70) ALDH1A1L3MBTL1TSHRGFERMAPK1
Hydrochloric Acid SCHEMBL8046146 0.83 ALDH1A1 (0.70) ALDH1A1L3MBTL1TSHRGFERMAPK1
SCHEMBL8038706 0.83 KMT2A (0.44) ALDH1A1L3MBTL1TSHRGFERMAPK1
SCHEMBL1972710 0.80 ALDH1A1 (0.67) ALDH1A1L3MBTL1TSHRGFERMAPK1
SCHEMBL332675 0.80 ALDH1A1 (0.67) ALDH1A1L3MBTL1TSHRGFERMAPK1
SCHEMBL15127584 0.80 EGFR (0.41) ALDH1A1L3MBTL1TSHRGFERMAPK1
SCHEMBL4809598 0.79 APP (0.41) ALDH1A1L3MBTL1TSHRGFERMAPK1
SCHEMBL7153357 0.78 ALDH1A1 (0.64) ALDH1A1L3MBTL1TSHRGFERMAPK1
Formaldehyde SCHEMBL28197258 0.78 ALDH1A1 (0.65) ALDH1A1L3MBTL1TSHRGFERMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230384496-A1 OPTICAL MEMBER FOR USE IN DISPLAY DEVICE AND DISPLAY DEVICE INCLUDING DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-11-30 US disclosed
US-11789307-B2 Colorant filter, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2023-10-17 US disclosed
US-20230288748-A1 LIGHT ABSORPTION FILTER, OPTICAL FILTER, SELF-LUMINOUS DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE, AND MANUFACTURING METHOD FOR OPTICAL FILTER FUJIFILM CORPORATION (JP) 2023-09-14 US disclosed
US-20230125712-A1 SELF-LUMINOUS DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-04-27 US disclosed
US-20230026009-A1 WAVELENGTH SELECTIVE ABSORPTION FILTER, POLARIZING PLATE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-01-26 US disclosed
US-20230012898-A1 LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2023-01-19 US disclosed
US-20220223825-A1 LAMINATE AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2022-07-14 US disclosed
US-20210026199-A1 COLORANT FILTER, BACKLIGHT UNIT, AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2021-01-28 US disclosed
US-20210005673-A1 COLOR CORRECTION FILTER FOR WHITE ORGANIC ELECTROLUMINESCENT LIGHT SOURCE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2021-01-07 US disclosed
US-20200369890-A1 RESIN COMPOSITION, FILM, OPTICAL FILTER, IMAGE DISPLAY DEVICE, SOLID-STATE IMAGING ELEMENT, AND COMPOUND FUJIFILM CORPORATION (JP) 2020-11-26 US disclosed
WO-2011106276-A1 TASK CHANNEL ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2011-09-01 WO disclosed
US-20100029952-A1 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems KENT STATE UNIVERSITY (US) 2010-02-04 US disclosed
US-20100029952-A1 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems KENT STATE UNIVERSITY (US) 2010-02-04 US disclosed
US-20100029952-A1 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems KENT STATE UNIVERSITY (US) 2010-02-04 US disclosed
US-5691349-A ANTICHOLESTEROL AGENTS; ATHEROSCLEROSIS ZENECA LIMITED (GB) 1997-11-25 US disclosed
EP-0654032-B1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS ZENECA LTD (GB) 1997-10-15 EP disclosed
EP-0654032-A1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS. ZENECA LTD (GB) 1995-05-24 EP disclosed
WO-1994003451-A1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS ZENECA LIMITED (GB) 1994-02-17 WO disclosed
US-4360511-A Amines useful as brain imaging agents MEDI-PHYSICS, INC. (US) 1982-11-23 US disclosed
US-4186153-A Process for 1,2,4,5-tetrachlorobenzene THE DOW CHEMICAL COMPANY (US) 1980-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230288748-A1 LIGHT ABSORPTION FILTER, OPTICAL FILTER, SELF-LUMINOUS DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE, AND MANUFACTURING METHOD FOR OPTICAL FILTER NLRP1, NLRP3, STRA6 ALDH1A1 293/4885L3MBTL1 986/4885TSHR 2218/4885
US-20100029952-A1 Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems MPI, ACR, PFAS ALDH1A1 1056/4885L3MBTL1 1877/4885TSHR 2426/4885
US-20230012898-A1 LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE EPCAM, ICAM1, STRA6 ALDH1A1 201/4885L3MBTL1 807/4885TSHR 3470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.